CERTEST
Founded in Zaragoza, Spain, in 2002, Certest Biotec is a leading biotechnology company specializing in in vitro diagnostics (IVD) for detecting viruses, bacteria, and parasites. Over two decades, Certest has expanded its reach to over 130 countries, delivering innovative diagnostic solutions to healthcare providers worldwide. With a team of more than 300 highly skilled professionals, the company combines scientific expertise and technological innovation to address global healthcare challenges, firmly establishing itself as a trusted leader in clinical diagnostics.
Certest’s advanced facilities include state-of-the-art molecular biology laboratories, clean rooms, and scalable production areas, spanning over 7,000 m². These facilities are not only designed to meet stringent quality requirements, certified under ISO 13485, but also reflect the company’s commitment to sustainability through the integration of energy-efficient technologies like photovoltaic solar systems. The infrastructure supports their capacity for high-volume production and rapid response to emerging diagnostic needs, ensuring reliable solutions on a global scale.
Guided by a mission to provide reliable, cutting-edge diagnostic tools, Certest continues to prioritize research and development as a cornerstone of its growth. By identifying new market opportunities and developing innovative products, the company seeks to advance diagnostic capabilities and improve patient outcomes. Their dedication to quality, innovation, and customer satisfaction drives their vision to lead the global IVD industry and make a lasting impact on global healthcare.
KAMPAL
Kampal Data Solutions was founded in 2014 as a spin-off from the University of Zaragoza and the BIFI Institute. The company brings together expertise in physics and computer engineering to develop cutting-edge solutions in artificial intelligence and machine learning. Kampal’s team includes renowned professors and researchers, with notable collaborations involving luminaries like Nobel Laureate Giorgio Parisi.
The company specializes in creating scalable, efficient, and user-friendly solutions designed for industries and research institutions in fields such as healthcare, biotechnology, and engineering. These solutions address complex challenges by leveraging advanced platforms like TensorFlow and Spark to handle diverse computational tasks. Kampal’s commitment to scientific rigor is reflected in its extensive contributions to optimization and network modeling, published in more than 200 scientific articles.
With a client-focused approach, Kampal ensures its solutions are tailored to meet specific objectives, delivering precision and actionable insights. By combining technical innovation with academic excellence, the company continues to provide impactful tools for data-driven decision-making.
CATEDRA EXOBIOPHARMA DE NANOMEDICINA
The Exobiopharma Chair in Nanomedicine was established in 2024 through a collaboration between the University of Zaragoza and the biopharmaceutical company Exobiopharma. Its goal is to advance research and education in the application of nanosciences to healthcare.
This initiative focuses on R&D, public outreach and education in areas like nanomaterials, nanomolecules, and exosomes. The chair aims to explore their clinical potential in medical fields such as oncology, tissue regeneration, immunomodulatory treatments for inflammation, and early disease diagnosis. In these areas, nanotechnology-based therapies hold the promise of more effective, personalized treatments, with the potential to significantly improve clinical outcomes and enhance patients’ quality of life.
The activities of the Chair include funding postgraduate scholarships to train specialists, organizing outreach events, and hosting conferences, seminars, and courses to enhance understanding of nanotechnology in human health.
